Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. Its reportable segments: (1) the development a... Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. Its reportable segments: (1) the development and commercialization of novel clean-surfaced nanotechnology therapeutics (Drugs, and (2) the development and commercialization of dietary supplements (Supplements). 더 보기
LOS ANGELES, Aug. 08, 2024 (GLOBE NEWSWIRE) -- via IBN – IBN, a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to...
기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.37 | 7.28346456693 | 5.08 | 5.66 | 4.81 | 83232 | 5.19971856 | CS |
4 | 1.3 | 31.3253012048 | 4.15 | 5.66 | 4.04 | 97380 | 4.86043834 | CS |
12 | -0.1 | -1.8018018018 | 5.55 | 6.5 | 3.85 | 79809 | 4.82394198 | CS |
26 | -1.19 | -17.921686747 | 6.64 | 7 | 3.8181 | 140782 | 5.36587595 | CS |
52 | -0.506 | -8.49563465413 | 5.956 | 11 | 3.8181 | 477960 | 7.46265787 | CS |
156 | -74.95 | -93.2213930348 | 80.4 | 102.6 | 3.8181 | 536706 | 29.34184661 | CS |
260 | -191.95 | -97.2391084093 | 197.4 | 356.4 | 3.8181 | 470050 | 53.96012195 | CS |
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관